Published in Cancer Treat Rep on April 17, 1980
Efficacy of ifosfamide, dacarbazine, doxorubicin and cisplatin in human sarcoma xenografts. Br J Cancer (1994) 0.77
A phase II Southwest Oncology Group study of cisplatin and continuous infusion vinblastine in the treatment of advanced soft tissue sarcoma. Invest New Drugs (1997) 0.76
VIP (etoposide, ifosfamide, and cisplatin) in patients with previously treated soft tissue sarcoma. Medicine (Baltimore) (2017) 0.75
Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg (1999) 3.56
Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol (2000) 3.42
Selective cytotoxicity of peritoneal leucocytes for neoplastic cells. Cell Immunol (1973) 3.17
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68
Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg (1993) 2.08
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06
Carcinoembryonic antigen (CEA) as a prognostic and monitoring test in clinically complete resection of colorectal carcinoma. Ann Surg (1976) 1.92
Metastatic patterns in soft-tissue sarcomas. Arch Surg (1983) 1.66
Results of salvage mastectomy for local recurrence after breast-conserving surgery without radiation therapy. Cancer (1993) 1.62
Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res (1986) 1.55
Desmoid tumour: a pleomorphic lesion. Eur J Surg Oncol (1999) 1.54
Leiomyosarcoma of the inferior vena cava: a clinicopathologic review and report of three cases. J Surg Oncol (1997) 1.46
Desmoid tumors in patients with familial adenomatous polyposis. Cancer (1994) 1.44
What is a surgical oncologist? Ann Surg Oncol (1994) 1.40
Detection of tumors in soft tissues by ultrasonic holography. Surg Gynecol Obstet (1969) 1.38
CEA monitoring among patients in multi-institutional adjuvant G.I. therapy protocols. Ann Surg (1982) 1.38
Survival in metastatic ocular melanoma. Cancer (1983) 1.37
Intravenous leiomyomatosis with cardiac extension: tumor thrombectomy through an abdominal approach. J Vasc Surg (2000) 1.35
CEA as a monitor of gastrointestinal malignancy. Cancer (1975) 1.33
Prognostic value of lymph node dissection in malignant melanoma. Arch Surg (1980) 1.24
Cytogenetic findings in liposarcoma correlate with histopathologic subtypes. Cancer (1992) 1.18
Cytogenetic profile of 109 lipomas. Cancer Res (1991) 1.18
Desmoid tumors and their management. Am J Surg (1985) 1.15
Carcinoembryonic antigen (CEA) in feces and plasma of normal subjects and patients with colorectal carcinoma. Dis Colon Rectum (1974) 1.15
Prognostic significance of lymph node metastasis and bone, major vessel, or nerve involvement in adults with high-grade soft tissue sarcomas. Cancer (1988) 1.13
CEA and tumor markers. Semin Oncol (1976) 1.13
Malignant soft tissue tumors of nerve sheath origin. J Surg Oncol (1984) 1.13
Complications and outcome of external hemipelvectomy in the management of pelvic tumors. Ann Surg Oncol (1996) 1.12
Liposarcomas: prognosis and management. J Surg Oncol (1980) 1.09
Reduced interferon response in mice congenitally infected with lymphocytic choriomeningitis virus. J Gen Virol (1970) 1.09
Evaluation of palliative resection in advanced carcinoma of the stomach. Surgery (1975) 1.08
Carcinoma of the colon, rectum, and anal canal in young patients. Surg Gynecol Obstet (1974) 1.07
Intussusception as a complication of malignant neoplasm. Arch Surg (1974) 1.06
Identification of a macromolecule containing an anticarcinoembryonic antigen-reactive substance and immunoglobulin M in human pancreatic cancer. J Natl Cancer Inst (1978) 1.05
Anorectal melanoma: clinical features, recurrence and patient survival. Int Surg (1981) 1.04
Survival of patients with stage B2 colon carcinoma. The Gastrointestinal Tumor Study Group experience. Arch Surg (1989) 1.02
Pyomyositis: a differential diagnosis from sarcoma. J Surg Oncol (1985) 1.02
Richter hernia of the stomach. J Surg Oncol (1998) 1.02
The surgical treatment and outcome of soft-tissue sarcoma. Arch Surg (1981) 1.01
Distant skin and soft tissue metastases from sarcomas. J Surg Oncol (1998) 1.01
Gastrointestinal metastases from malignant melanoma. Surg Oncol (1995) 1.01
Symptomatic gastrointestinal metastases from malignant melanoma. Cancer (1981) 1.00
Intraoperative photodynamic therapy for retroperitoneal sarcomas. Cancer (1988) 1.00
Treatment of unknown primary melanoma. Cancer (1991) 0.99
Hemipelvectomy. Arch Surg (1975) 0.99
Management of retroperitoneal sarcomas and patient survival. Am J Surg (1985) 0.99
Partial and complete internal hemipelvectomy: complications and long-term follow-up. J Am Coll Surg (1995) 0.99
The technique of popliteal lymph node dissection. Surg Gynecol Obstet (1980) 0.98
Report of a rare case of significant hemobilia and review of this entity. J Med (1982) 0.97
Primary malignant tumors of the upper extremity: retrospective analysis of one hundred twenty-six cases. J Hand Surg Am (1985) 0.96
CEA (carcinoembryonic antigen): its role as a marker in the management of cancer. J Cancer Res Clin Oncol (1981) 0.96
CEA monitoring of palliative treatment for colorectal carcinoma. Ann Surg (1977) 0.96
An apparent histoincompatibility between mice chronically infected with lymphocytic choriomeningitis virus and their uninfected syngeneic counterparts. Transplantation (1971) 0.95
Eccrine porocarcinoma. J Surg Oncol (1994) 0.95
Variants of hemipelvectomy. Am J Surg (1983) 0.95
Carcinoembryonic antigen. Current clinical status. N Y State J Med (1974) 0.94
The effect of local recurrence on survival time in adult high-grade soft tissue sarcomas. J Clin Epidemiol (1989) 0.94
Immunotherapeutic approaches to the management of neoplasms. Natl Cancer Inst Monogr (1972) 0.93
Pre- and postoperative uses of CEA. Cancer (1978) 0.93
Malignant melanoma of the gallbladder: report of a case and review of the literature. Am Surg (1995) 0.93
Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma. Eur J Surg Oncol (2001) 0.92
Isolation of glycoprotein antigen from ascites fluid of pancreatic carcinoma. Cancer Res (1977) 0.92
Estrogen and progesterone receptors and tamoxifen in malignant melanoma. Cancer Treat Rep (1981) 0.91
Murine colon adenocarcinoma: syngeneic orthotopic transplantation and subsequent hepatic metastases. J Natl Cancer Inst (1977) 0.91
Mesenteric fibromatosis in Gardner's syndrome. Arch Surg (1978) 0.90
Attributes and survival patterns of multiple primary cutaneous malignant melanoma. Cancer (1991) 0.90
Feasibility of limb salvage and survival in soft tissue sarcomas. Cancer (1986) 0.90
Subungual melanoma: an eighteen-year review. Surgery (1994) 0.90
Blood groups and malignant melanoma. J Surg Oncol (1986) 0.88
Hilar hepatojejunostomy in resection of carcinoma of the main hepatic duct junction. Surg Gynecol Obstet (1977) 0.88
Prognostic parameters in recurrent malignant melanoma. Cancer (1983) 0.88
Leukocyte adherence inhibition: an automated microassay demonstrating specific antigen recognition and blocking activity in two murine tumor systems. J Immunol Methods (1977) 0.88
Immunologic approaches to the management of primary and secondary tumors involving the skin and soft tissues: review of a ten-year program. Transplant Proc (1975) 0.88
Malignant melanoma of the anorectal region. J Surg Oncol (1995) 0.88
Various types of hemipelvectomy for soft tissue sarcomas: complications, survival and prognostic factors. Surg Oncol (1995) 0.87
New surgical approaches to pancreatic cancer. Cancer (1981) 0.87
A statistical evaluation of baseline and follow-up carcinoembryonic antigen in patients with resectable colorectal carcinoma. Cancer (1981) 0.87
Gastrocolic fistula as a complication of benign gastric ulcer. Arch Surg (1979) 0.87
Rejection of skin grafts from mice chronically infected with Lymphocytic choriomeningitis virus by non-infected syngeneic recipients. Nature (1969) 0.86
Murine colon adenocarcinomas: methods for selective culture in vitro. J Natl Cancer Inst (1976) 0.86
Abdominal wall replacement with plastic mesh in ablative cancer surgery. Surgery (1975) 0.86
Clinical factors and treatment parameters affecting prognosis in adult high-grade soft tissue sarcomas: a retrospective review of 267 cases. Eur J Surg Oncol (1989) 0.86
Biologic behavior and treatment of intransit metastasis of melanoma. Surg Gynecol Obstet (1980) 0.86
Tumor cell destruction by macrophages. J Med (1972) 0.86
Pancreatic cancer. Initial treatment as the determinant of survival. JAMA (1974) 0.86
Tumor size/symptom duration ratio as a prognostic factor in patients with high-grade soft tissue sarcomas. Eur J Cancer Clin Oncol (1988) 0.86
Endocrine organ metastases in subjects with lobular carcinoma of the breast. Arch Surg (1993) 0.86
Adrenal adenocarcinomas: histologic grading and survival. J Surg Oncol (1985) 0.86
Axillary node dissection in malignant melanoma. Surg Gynecol Obstet (1981) 0.85
Tourniquet infusion versus hyperthermic perfusion. Cancer (1982) 0.85
Tumor thromboplastic activity in vitro. Int J Cancer (1972) 0.85
A carcinoembryonic antigen standardization experiment for the conduct of multi-institutional clinical trials. Gastrointestinal Tumor Study Group. Cancer Treat Rep (1980) 0.85
High-dose methotrexate as secondary chemotherapy in metastatic soft-tissue sarcomas. Cancer (1980) 0.84
Axillary compression syndrome with neurapraxia due to operative positioning. Surgery (1989) 0.84
Comparison of prognostic factors for survival and recurrence in malignant melanoma of the skin, clinical Stage I. Cancer (1985) 0.84